Hypochondroplasia in a child with 1620C>G (Asn540Lys) mutation in FGFR3

J Clin Res Pediatr Endocrinol. 2012 Dec;4(4):220-2. doi: 10.4274/jcrpe.787. Epub 2012 Nov 12.

Abstract

Hypochondroplasia (HCP) is an autosomal dominant skeletal dysplasia characterized by short extremities, short stature and lumbar lordosis, usually exhibiting a phenotype similar to but milder than achondroplasia (ACP). Fibroblast growth factor receptor 3 gene (FGFR3) mutations in the germline are well-known causes of skeletal syndromes. FGFR3 is a negative regulator of bone growth and all mutations in FGFR3 are gain-of-function mutations that lead to skeletal dysplasias. We report a child who presented with short stature, a relatively long trunk, short legs, short arm span, radiographic evidence of HCP and mild mental retardation. Genetic analysis revealed a heterozygous 1620C>G (Asn540Lys) mutation in FGFR3. To our knowledge, ours is the first case report of HCP with a heterozygous 1620C>G (Asn540Lys) mutation in Turkey.

Publication types

  • Case Reports

MeSH terms

  • Amino Acid Substitution
  • Bone and Bones / abnormalities
  • Bone and Bones / metabolism
  • Child Development
  • Child, Preschool
  • Dwarfism / genetics*
  • Dwarfism / metabolism
  • Exons
  • Female
  • Heterozygote
  • Humans
  • Limb Deformities, Congenital / genetics*
  • Limb Deformities, Congenital / metabolism
  • Lordosis / genetics*
  • Lordosis / metabolism
  • Mutation*
  • Receptor, Fibroblast Growth Factor, Type 3 / genetics*
  • Receptor, Fibroblast Growth Factor, Type 3 / metabolism

Substances

  • FGFR3 protein, human
  • Receptor, Fibroblast Growth Factor, Type 3

Supplementary concepts

  • Hypochondroplasia